Nutex Health Inc. (NUTX)

Nasdaq: NUTX · Services-Business Services, NEC · Houston, TX · filing with the SEC since 2009

Full chart Alerts Compare

Grade5.2

◀ Past 3.2● Present 6.2▶ Future 5.6

1 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

The grade of Nutex Health Inc.

Nine metrics read from its own filings, by tense

Headline grade

5.2/10

◀ Past3.225% of the headline

● Present6.235% of the headline

▶ Future5.640% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 8 read as filed from the record and 1 is an SI estimate, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

3.2/1025% of the headline grade · 3 of 3 filed

Surviving crises

as filed

0.2/10

Has it survived what it has been through?

34 warning events since 2017; the latest 2026-08-31.

weight 22% of this tense · 2nd percentile among 105 sector filers · read for itself

From the record

Nutex Health Inc.'s filings since 2017 show 34 warning events of 5 kinds: a notice about its exchange listing (8-K item 3.01, 6 times, the latest 2025-10-20); a warning not to rely on past financial statements (8-K item 4.02, 2 times, the latest 2025-08-21); an auditor change (8-K item 4.01, 4 times, the latest 2025-05-21); a material cybersecurity incident (8-K item 1.05, the latest 2026-08-31); a late-report notice (Form NT 10-K or NT 10-Q, 21 times, the latest 2025-11-17) (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed

5.5/10

What has it actually done, year after year?

+273.4% a year over 9 filed years; profitable in 5 of 9.

weight 45% of this tense · 55th percentile among 99 sector filers · read for its customers

From the record

Nutex Health Inc.'s 9 filed years say what it did: revenue went from $23 thousand in fiscal 2017 to $875 million in fiscal 2025, up 273.4% a year; it rose in 6 of 8 years; the deepest fall was 34% from fiscal 2021 to fiscal 2022; net income was positive in 5 of 9 of those years (its annual reports).

What it rests on

revenue growth over the filed span273.4%top 1% of its family
the share of years revenue rosebottom 41% of its family
the share of filed years with a profittop 45% of its family
the deepest fall from a revenue peak33.9%bottom 26% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

as filed

1.9/10

How has it treated the people who own it?

Share count grew 16.9% a year. 2% of cash flow returned. Insiders: 1 sales, 5 purchases.

weight 33% of this tense · 19th percentile among 70 sector filers · read for its shareholders

From the record

Over the 3 fiscal years to 2025-12-31, Nutex Health Inc.'s diluted share count grew about 16.9% a year, and dividends and buybacks returned about 2% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 1 sale and 5 purchases of their own stock on the open market in the year to 2026-09-30, buying about $148 thousand (their Form 4 filings).

What it rests on

the share count over the yearsbottom 15% of its family
cash returned against operating cash flowbottom 24% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

● Present

What are they doing right now?

6.2/1035% of the headline grade · 2 of 3 filed, 1 estimated

Financial health

as filed

5.9/10

Is it financially healthy right now?

ROE 17%: 17¢ of profit per shareholder dollar. Leverage 54%: owes 54¢ per asset dollar.

weight 33% of this tense · 59th percentile among 98 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, Nutex Health Inc. earned about 17 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 48 cents per dollar of everything the company owns. Leverage: it owed about 54 cents per dollar of assets, and net share issuance: its share count grew 23.0% over the year (the filed statements).

What it rests on

what it owes per dollar of assetstop 37% of its family
return on equitytop 29% of its family
gross profit against assetstop 13% of its family
the share count against the year beforebottom 15% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed

7.0/10

How strong is its position in its industry?

top 30% of 101 in its family; net margin 8.1%.

weight 45% of this tense · 70th percentile among 101 sector filers · read for its customers

From the record

Nutex Health Inc.'s standing among 101 graded names in its industry family: revenue of $875 million in fiscal 2025 ranks in the bottom 45% by size; a net margin of 8.1% ranks in the top 32%; revenue growth of 58.6% a year over the last 3 filed years ranks in the top 1% (its annual reports).

What it rests on

revenue against the family$875Mbottom 45% of its family
net margin8.1%top 32% of its family
three-year revenue growth58.6%top 1% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

SI estimate

4.8/10

What are the people in charge doing?

SI estimate 4.8/10, confidence 35 of 100 (one part).

weight 22% of this tense · 48th percentile among 75 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate: Read from one part only, officer and director changes on Form 8-K over three years, against the people in charge, which ranks in the bottom 48% of 75 in its family; the record of its people begins on 2022-03-07 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 4.6 years and cannot see past it; a floor under five years is not read as years in charge.
What the record cannot read: The record of its people begins on 2022-03-07 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 4.6 years and cannot see past it; a floor under five years is not read as years in charge.
How it was reasoned: one part: officer and director changes on Form 8-K, against the people in charge, the one part on file, ranked among 75 in its family.
Confidence: 35 of 100
What would change it: A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Nutex Health Inc.'s leadership is put at 4.8 of 10 with a confidence of 35 of 100, because read from one part only, officer and director changes on Form 8-K over three years, against the people in charge, which ranks in the bottom 48% of 75 in its family; the record of its people begins on 2022-03-07 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 4.6 years and cannot see past it; a floor under five years is not read as years in charge. A filing that carries the missing parts replaces this estimate with the filed reading.

▶ Future

What are they set up to do next?

5.6/1040% of the headline grade · 3 of 3 filed

Room to expand

as filed

7.2/10

How much room does it have to grow?

top 28% of 99 in its family for room to expand.

weight 33% of this tense · 72nd percentile among 99 sector filers · read for itself

From the record

Nutex Health Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $186 million against debt of $29 million leaves 17% of its assets as net cash, top 27% of its family; cash from operations less capital spending is 28.1% of revenue (top 13%); a gross margin of 50.8% (top 46%) (its annual report).

What it rests on

cash less debt against assets17.0%top 27% of its family
cash from operations less capital spending against revenue28.1%top 13% of its family
gross margin50.8%top 46% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed

2.9/10

What could actually drive growth from here?

bottom 29% of 99 in its family for growth drivers.

weight 45% of this tense · 29th percentile among 99 sector filers · read for its customers

From the record

Nutex Health Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 58.6% a year over the last three filed years against 273.4% over all 9, slowing (bottom 1% of its family); the newest year grew 82.4% (top 4%); research spending grew -19.4% a year (bottom 9%); capital spending grew -44.3% a year (bottom 10%) (its annual reports). Nutex Health Inc. reported 2 product lines in fiscal 2025: Hospital Division at $844 million (96%), Population Health Management Division at $31 million (4%); 2 of 2 grew against the year before (its annual report).

What it rests on

three-year growth against the whole span-214.8 points a yearbottom 1% of its family
the newest year's revenue growth82.4%top 4% of its family
three-year growth of research spending-19.4%bottom 9% of its family
three-year growth of capital spending-44.3%bottom 10% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

as filed

8.6/10

Did its newest year beat what its own record pointed to?

top 14% of 93 in its family for expectations against reality.

weight 22% of this tense · 86th percentile among 93 sector filers · read for its shareholders

From the record

Nutex Health Inc.'s newest year against its own record: revenue of $875 million in fiscal 2025 came in 23.3% above the $710 million its prior three years' pace pointed to (top 10% of its family); net income of $71 million against a prior three-year average of $139 million (top 20%); a net margin of 8.1% against -67.1% before (top 11%) (its annual reports).

What it rests on

revenue against the prior three years' pace23.3%top 10% of its family
net income against the prior three years' average+151%top 20% of its family
net margin against its prior average+75.2 pointstop 11% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton NUTX · research, not advice